MQS Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,769
| Closed | -$204K | – | 254 |
|
|
2024
Q3 | $204K | Sell |
1,769
-1,103
| -38% | -$127K | 0.11% | 371 |
|
|
2024
Q2 | $395K | Sell |
2,872
-1,126
| -28% | -$155K | 0.24% | 167 |
|
|
2024
Q1 | $551K | Buy |
+3,998
| New | +$551K | 0.32% | 102 |
|
|
2023
Q3 | – | Sell |
-3,024
| Closed | -$285K | – | 557 |
|
|
2023
Q2 | $285K | Buy |
3,024
+11
| +0.4% | +$1.04K | 0.19% | 241 |
|
|
2023
Q1 | $305K | Buy |
+3,013
| New | +$305K | 0.2% | 230 |
|